Frequency and Consequences of Cognitive Impairment in Patients Underwent Transcatheter Aortic Valve Implantation

Ryo Yanagisawa, Makoto Tanaka, Fumiaki Yashima, Takahide Arai, Takashi Kohno, Hideyuki Shimizu, Keiichi Fukuda, Toru Naganuma, Kazuki Mizutani, Motoharu Araki, Norio Tada, Futoshi Yamanaka, Shinichi Shirai, Minoru Tabata, Hiroshi Ueno, Kensuke Takagi, Akihiro Higashimori, Yusuke Watanabe, Masanori Yamamoto, Kentaro Hayashida

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cognitive impairment is common in patients underwent transcatheter aortic valve implantation (TAVI) and might affect procedure outcomes. This study evaluated the incidence of preprocedural cognitive impairment and its impact on clinical outcomes after TAVI. We analyzed the data of 1,111 patients (age ≥70 years) obtained from the Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) registry. The cognitive performance of all patients was assessed using the Mini-Mental State Examination (MMSE) at baseline. We evaluated the 1-year cumulative mortality after TAVI according to the MMSE performance. Cognitive impairment was present in 420 (38%) of 1,111 patients. Compared with patients with normal cognition, those with cognitive impairment showed higher cumulative all-cause and noncardiovascular mortality rates at 1 year (14% vs. 8%, p = 0.001; 11% vs. 5%, p <0.001, respectively). Moreover, cognitive impairment increased the risk of mortality from sepsis (2% vs. 0.4%; hazard ratio, 4.2; 95% confidence interval, 1.3 to 13.5; p = 0.02). In adjusted models, cognitive impairment was an independent risk factor for 1-year all-cause mortality (adjusted hazard ratio, 2.1; 95% confidence interval, 1.1 to 4.0; p = 0.02). Although patients with cognitive impairment had more in-hospital adverse outcomes, including prolonged hospital stays, major bleeding and vascular complications, and acute kidney injury, than did those with normal cognition, the 30-day mortality was similar between the groups (1% in the two groups; p >0.99). In conclusion, cognitive impairment based on the MMSE score was an independent predictor of mortality at 1 year after TAVI.

Original languageEnglish
JournalAmerican Journal of Cardiology
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Mortality
Cognition
Registries
Cohort Studies
Catheters
Transcatheter Aortic Valve Replacement
Cognitive Dysfunction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Frequency and Consequences of Cognitive Impairment in Patients Underwent Transcatheter Aortic Valve Implantation. / Yanagisawa, Ryo; Tanaka, Makoto; Yashima, Fumiaki; Arai, Takahide; Kohno, Takashi; Shimizu, Hideyuki; Fukuda, Keiichi; Naganuma, Toru; Mizutani, Kazuki; Araki, Motoharu; Tada, Norio; Yamanaka, Futoshi; Shirai, Shinichi; Tabata, Minoru; Ueno, Hiroshi; Takagi, Kensuke; Higashimori, Akihiro; Watanabe, Yusuke; Yamamoto, Masanori; Hayashida, Kentaro.

In: American Journal of Cardiology, 01.01.2018.

Research output: Contribution to journalArticle

Yanagisawa, R, Tanaka, M, Yashima, F, Arai, T, Kohno, T, Shimizu, H, Fukuda, K, Naganuma, T, Mizutani, K, Araki, M, Tada, N, Yamanaka, F, Shirai, S, Tabata, M, Ueno, H, Takagi, K, Higashimori, A, Watanabe, Y, Yamamoto, M & Hayashida, K 2018, 'Frequency and Consequences of Cognitive Impairment in Patients Underwent Transcatheter Aortic Valve Implantation', American Journal of Cardiology. https://doi.org/10.1016/j.amjcard.2018.05.026
Yanagisawa, Ryo ; Tanaka, Makoto ; Yashima, Fumiaki ; Arai, Takahide ; Kohno, Takashi ; Shimizu, Hideyuki ; Fukuda, Keiichi ; Naganuma, Toru ; Mizutani, Kazuki ; Araki, Motoharu ; Tada, Norio ; Yamanaka, Futoshi ; Shirai, Shinichi ; Tabata, Minoru ; Ueno, Hiroshi ; Takagi, Kensuke ; Higashimori, Akihiro ; Watanabe, Yusuke ; Yamamoto, Masanori ; Hayashida, Kentaro. / Frequency and Consequences of Cognitive Impairment in Patients Underwent Transcatheter Aortic Valve Implantation. In: American Journal of Cardiology. 2018.
@article{b45be78203f5480a9a5c304e1f3fc2a9,
title = "Frequency and Consequences of Cognitive Impairment in Patients Underwent Transcatheter Aortic Valve Implantation",
abstract = "Cognitive impairment is common in patients underwent transcatheter aortic valve implantation (TAVI) and might affect procedure outcomes. This study evaluated the incidence of preprocedural cognitive impairment and its impact on clinical outcomes after TAVI. We analyzed the data of 1,111 patients (age ≥70 years) obtained from the Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) registry. The cognitive performance of all patients was assessed using the Mini-Mental State Examination (MMSE) at baseline. We evaluated the 1-year cumulative mortality after TAVI according to the MMSE performance. Cognitive impairment was present in 420 (38{\%}) of 1,111 patients. Compared with patients with normal cognition, those with cognitive impairment showed higher cumulative all-cause and noncardiovascular mortality rates at 1 year (14{\%} vs. 8{\%}, p = 0.001; 11{\%} vs. 5{\%}, p <0.001, respectively). Moreover, cognitive impairment increased the risk of mortality from sepsis (2{\%} vs. 0.4{\%}; hazard ratio, 4.2; 95{\%} confidence interval, 1.3 to 13.5; p = 0.02). In adjusted models, cognitive impairment was an independent risk factor for 1-year all-cause mortality (adjusted hazard ratio, 2.1; 95{\%} confidence interval, 1.1 to 4.0; p = 0.02). Although patients with cognitive impairment had more in-hospital adverse outcomes, including prolonged hospital stays, major bleeding and vascular complications, and acute kidney injury, than did those with normal cognition, the 30-day mortality was similar between the groups (1{\%} in the two groups; p >0.99). In conclusion, cognitive impairment based on the MMSE score was an independent predictor of mortality at 1 year after TAVI.",
author = "Ryo Yanagisawa and Makoto Tanaka and Fumiaki Yashima and Takahide Arai and Takashi Kohno and Hideyuki Shimizu and Keiichi Fukuda and Toru Naganuma and Kazuki Mizutani and Motoharu Araki and Norio Tada and Futoshi Yamanaka and Shinichi Shirai and Minoru Tabata and Hiroshi Ueno and Kensuke Takagi and Akihiro Higashimori and Yusuke Watanabe and Masanori Yamamoto and Kentaro Hayashida",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.amjcard.2018.05.026",
language = "English",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Frequency and Consequences of Cognitive Impairment in Patients Underwent Transcatheter Aortic Valve Implantation

AU - Yanagisawa, Ryo

AU - Tanaka, Makoto

AU - Yashima, Fumiaki

AU - Arai, Takahide

AU - Kohno, Takashi

AU - Shimizu, Hideyuki

AU - Fukuda, Keiichi

AU - Naganuma, Toru

AU - Mizutani, Kazuki

AU - Araki, Motoharu

AU - Tada, Norio

AU - Yamanaka, Futoshi

AU - Shirai, Shinichi

AU - Tabata, Minoru

AU - Ueno, Hiroshi

AU - Takagi, Kensuke

AU - Higashimori, Akihiro

AU - Watanabe, Yusuke

AU - Yamamoto, Masanori

AU - Hayashida, Kentaro

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Cognitive impairment is common in patients underwent transcatheter aortic valve implantation (TAVI) and might affect procedure outcomes. This study evaluated the incidence of preprocedural cognitive impairment and its impact on clinical outcomes after TAVI. We analyzed the data of 1,111 patients (age ≥70 years) obtained from the Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) registry. The cognitive performance of all patients was assessed using the Mini-Mental State Examination (MMSE) at baseline. We evaluated the 1-year cumulative mortality after TAVI according to the MMSE performance. Cognitive impairment was present in 420 (38%) of 1,111 patients. Compared with patients with normal cognition, those with cognitive impairment showed higher cumulative all-cause and noncardiovascular mortality rates at 1 year (14% vs. 8%, p = 0.001; 11% vs. 5%, p <0.001, respectively). Moreover, cognitive impairment increased the risk of mortality from sepsis (2% vs. 0.4%; hazard ratio, 4.2; 95% confidence interval, 1.3 to 13.5; p = 0.02). In adjusted models, cognitive impairment was an independent risk factor for 1-year all-cause mortality (adjusted hazard ratio, 2.1; 95% confidence interval, 1.1 to 4.0; p = 0.02). Although patients with cognitive impairment had more in-hospital adverse outcomes, including prolonged hospital stays, major bleeding and vascular complications, and acute kidney injury, than did those with normal cognition, the 30-day mortality was similar between the groups (1% in the two groups; p >0.99). In conclusion, cognitive impairment based on the MMSE score was an independent predictor of mortality at 1 year after TAVI.

AB - Cognitive impairment is common in patients underwent transcatheter aortic valve implantation (TAVI) and might affect procedure outcomes. This study evaluated the incidence of preprocedural cognitive impairment and its impact on clinical outcomes after TAVI. We analyzed the data of 1,111 patients (age ≥70 years) obtained from the Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) registry. The cognitive performance of all patients was assessed using the Mini-Mental State Examination (MMSE) at baseline. We evaluated the 1-year cumulative mortality after TAVI according to the MMSE performance. Cognitive impairment was present in 420 (38%) of 1,111 patients. Compared with patients with normal cognition, those with cognitive impairment showed higher cumulative all-cause and noncardiovascular mortality rates at 1 year (14% vs. 8%, p = 0.001; 11% vs. 5%, p <0.001, respectively). Moreover, cognitive impairment increased the risk of mortality from sepsis (2% vs. 0.4%; hazard ratio, 4.2; 95% confidence interval, 1.3 to 13.5; p = 0.02). In adjusted models, cognitive impairment was an independent risk factor for 1-year all-cause mortality (adjusted hazard ratio, 2.1; 95% confidence interval, 1.1 to 4.0; p = 0.02). Although patients with cognitive impairment had more in-hospital adverse outcomes, including prolonged hospital stays, major bleeding and vascular complications, and acute kidney injury, than did those with normal cognition, the 30-day mortality was similar between the groups (1% in the two groups; p >0.99). In conclusion, cognitive impairment based on the MMSE score was an independent predictor of mortality at 1 year after TAVI.

UR - http://www.scopus.com/inward/record.url?scp=85050665211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050665211&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2018.05.026

DO - 10.1016/j.amjcard.2018.05.026

M3 - Article

C2 - 30072128

AN - SCOPUS:85050665211

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

ER -